leading for this method to be de - scribed by the industry as golden standard without the availability of adequate data. Fur thermore, the ef- fectiveness of the method is also gu- aranteed in combination with auto- logous bone grafts61. At present sole use of PRP with bone substitute materials without autologous spon- giosa in sinus lift processes must be regarded as ques tionable. Author’s Address: Dr. Mehrdad Arjomand Dentist Mellmannweg 9 22041 Hamburg, Germany E-Mail: arjomani@t-online.de References 1 Keneley RA, Yim K, Abrams J, Ron E, Turek T, Mar- den LJ, Hollinger JO: Biotechnology and bone graft substitutes. Pharmaceut Res 1993; 10: 1393–1401. 2 Fox R: New bone? The Lancet 1992; 339: 463–464. 3 Teschner M, Küsswetter W: Gentechnisch induzier- tes Knochenwachstum. Dt Ärztebl 1999; 96: A- 1891–1896 [Heft 28–29]. 4 Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD: Molecular biology of the cell. 3. Edition – Wein- heim; New York, Basel; Cambridge; Tokyo: VCH 1995. 5 Clark WE Le Gros: The Tissues of the body, 6th ed. Oxford, UK: Clarendon Press, 1971. 18 Heldin CH: Structural and functional studies on platelet-derived growth factor. EMBO J. 1992; 11: 4251–4259. 19 Massagué J: The transforming growth factor- fa- mily. Annu Rev Cell Biol 1990; 6: 597–641. 20 Massagué J, Pandiella A: Membrane-anchored growth factors. Annu Rev Biochem 1993; 62: 515– 541. 21 Ross R, Raines EW, Bowen-Pope DF: The biology of platelet-derived growth factor. Cell 1986; 46: 155– 169. 22 Sporn MB, Roberts AB: Peptide Growth Factors and Receptors. Berlin: Springer-Verlag, 1990. 23 Levander G: A study of bone regeneration surgery. Surg Gynecol Obstet 1908; 67: 705–712. 24 Sampath TK, Reddi AH: Homology of bone induc- tive proteins from human monkey, bovine and rat extracellular Matrix. Proc Natl Acad Sci USA 1983; 80: 6591–6595. 25 Takaoka K, Yoshikawa H, Masuhara K et al.: Esta- blishing of a cell line producing bone morphoge- netic protein from a human osteosarcoma. Clin Or- thop 1989; 244: 258–264. 26 Wang EA et al.: Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988; 85: 9484–9688. 27 Rosen V, Cox K, Hattersley G: Bone morphoge- netic proteins. In: Bilezkian, Raisz, Rodan (eds), Principles of bone biology. Academic Press 1996; 47: 661–672. 28 Wozney JM: Molecular biology of the bone mor- phogenetic proteins. In: Bone Grafts, Derivatives and substitutes; Urist MR, O’Conner BT, Burwell RG (eds); London: Butterworth Heinemann 1994; 397–413. 29 Wozney JM: The potential role of bone morphoge- nic proteins in periodontal reconstruction. Peri- odont 1995; 66: 506–510. 30 Ripamonti U, Reddi AH: Periodontal regeneration: Potential role of bone morphogenetic proteins. Pe- riodont Res 1994; 29: 225–235. 31 Reddi AH, Weientroub S, Muthukumaran N: Bio- logic principles of bone induction. Orthopedic Clin North America 1987; 18: 207–212. 32 Lianjia Y, Yan J: Immunohistochemical observati- ons on bone morphogenetic protein in normal and abnormal conditions. Clin Orthopaed and Relat Res 1990; 257: 249–256. 33 Marcus R: Normal and abnormal bone remodeling 6 Watt FM: Cell culture models of differentiation. FA- in man. Annu rev med 1987; 38: 129–141. SEB J. 1991; 5: 287–294. 7 Weiss PA: Principles of Development, 289–437. New York: Holt, 1939. 8 Graziadei PPC, Monti Graziadei GA: Continuous nerve cell renewal in the olfactory system. In Hand- book of sensory Physiology; Vol. IX: Development of sensory systems (M. Jacobson, ed.), 55–82. New York: Springer-Verlag, 1978. 9 Fawcett DW (Bloom and Fawcett): A Textbook of Hi- stology, 11th ed., 136–187. Philadelphia: Saunders, 1986. 10 Gabbiani G, Rungger-Brändle E: The Fibroblast. In Tissue Repair and Regeneration (LE Glynn, ed.), 1– 50. Handbook of Inflammation, Vol. 3. Amsterdam: Elsevier, 1981. 11 Clark RAF, Henson PM, eds. The Molecular and cel- lular Biology of Wound Repair. New York: Plenum Press, 1988. 12 Conrad GW, Hart GW, Chen Y: Differences in vitro between fibroblast-like cells cornea, heart, an skin of embryonic chicks. J. cell sci.1977; 26: 119–137. 13 Reddi AH, Gay R, Gay S, Miller EJ: Transitions in collagen types during matrix-induced cartilage bone, and bone marrow formation. Proc. Natl. Acad. Sci. USA 1977; 74: 5589–5592. 14 Rosen v, Thies RS: The BMP proteins in bone forma- tion and repair. Trends Genet.1992; 8: 97-102. 15 Schor SL, Schor AM: Clonal heterogeneity in fibro - blast phenotype: implications for the control of epithelial-mesenchymal interactions. Bioassays 1987; 7: 200–204. 16 Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whit- ters MJ, Kriz RW, Hewik RM, Wang E: Novel regula- tors of bone formation: molecular clones and activi- ties. Science 1988; 242: 1527–1534. 17 Cross M, Dexter TM: Growth factors in develop- ment, transformation, and tumorigenesis. Cell 1991; 64: 271–280. 34 Osdoby P, Krukowski M, Oursler MJ, Salino-Hugg T: The origin, development, and regulation of osteoclasts. Bioassays 1987; 7: 30–34. 35 Vaughan J: The physiology of Bone, 3rd ed. Oxford, UK: Clarendon Press, 1981. 36 Nakase T et al.: Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Mineral Res 1994; 9: 651–659. 37 Niederwanger M, Urist MR: Demineralized bone matrix supplies by bone banks for a carrier of re- combinant human bone morphogenetic protein- 2(rhBMP-2): A substitute for autogenic bone grafts. J Oral Implant 1996; 22: 210–211. 38 Lindholm TS, Gao TJ: Functional carriers for bone morphogenetic proteins. Ann Chir Gynaecol 1993; 207: 3–12. 39 Terheyden H, Jepsen S: Wachstumsfaktoren und morphogene Proteine. Implantologie 1999; 4: 359–378. 40 Ripamonti U, Ma S, Reddi AH: The clinical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone mor- phogenetic protein. Matrix 1992; 12: 202–212. 41 Ripamonti U, Duneas N: Tissue morphogenesis and regeneration by bone morphogenetic proteins. Plast Reconstr Surg 1998; 101: 227–239. 42 Sampath K, Reddi H: Importance of the geometry of the extracellular matrix in enchondral bone diffe- rentiation. J Cell Biol 1984; 98: 2192–2197. 43 Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M, Murata M, Nagai N, Ohgushi H: BMP-Induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J Biomed Mater Res 1998; 39: 190–199. 44 Terheyden H, Jepsen S, Vogler S, Tucker MM, Rue- ger C: Recombinant human osteogenic protein-1 TECHNICAL REPORT (rhBMP-7) in the rat mandibular augmentation model: Differences in bone morphology are de- pendent on the type of carrier. Mund Kiefer Ges Chir 1997; 1: 272–275. 45 Van Eeden SP, Ripamonti U: Bone differentiation in porous hydroxyapatite in baboons in regulated by the geometry of the substratum: Implications for re- constructive craniofacial surgery. Plast Reconstr Surg 1994; 93: 959–966. 46 Terheyden H, Jepsen S, Möller B, Tucker MM, Rue- ger DC: Sinus floor augmentation with simulta- neous placement of dental implants using a combi- nation of deproteinized bone xenografts and re- combinant human osteogenic protein-1. A histo- metric study in minipigs. Clin Oral Implants 1999; 10: 510–521. 47 Hanisch O, Tatakis DN, Rohrer MD, Wöhrle PS, Wozney JM, Wikesjö UME: Bone formation and os- seointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 1997; 12: 785–792. 48 Margolin MD, Cogan AG, Taylor M, Buck D, Mc Alister TN, Toth C, Mc Alister B: Maxillary sinus augmentation in the non human primate. A com- parative radiographic and histologic study between recombinant human osteogenic protein-1 and na- tural bone mineral. J Periodontol 1998; 69: 911– 919. 49 Mc Alliater BS, Margolin MD, Cogan AG, Taylor M, Wollins J: Residual lateral wall defects following sinus grafting with recombinant human osteo- genic protein-1 or Bio-Oss in the chimpanzee. Int J Periodontics Restorative Dent 1998; 18: 227– 239. 50 Kiker-Head CA, Nevins M, Palmer R, Nevins ML, Schelling SH: A new animal model for maxillary si- nus floor augmentation: Evaluation parameters. Int J Oral Maxillofac Implants 1997; 12: 403–411. 51 Sigurdsson TJ, FU E, Takakis D, Rohrer M, Wikesjö UME: Bone morphogenetic protein-2 for peri-im- plant bone regeneration and osseointegration. Clin Oral Implants Res 1997; 375–385. 52 Cochran Dl, Nummikoski PV, Jones AA, Makins SR, Turek T, Buser D: Radiographic analysis of regene- rated bone around endosseous implants in the ca- nine using recombinant bone morphogenetic pro- tein-2. Int J Oral Maxillofac Implants 1997; 12: 739–748. 53 Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UME: Bone formation and osseointegra- tion in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Im- plants 1997; 12: 604–610. 54 Sandhu HS, Kanim LE, Toth JM, Kabo JM, Liu D, De- lamarter RB, Dawson EG: Experimental spinal fu- sion with recombinant human bone morphogene- tic protein-2 without decortication of osseous ele- ments. Spine 1997; 22: 1171–1180. 55 Bostrom M, Lane JM, Tomin E, Browne M, Berbe- rian W, Turek T, Shmith i, Wozney J, Schildhauer T: Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Ortop 1996; 327: 272– 282. 56 Boyne P, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Adler M, Nummikoski P: A feasibility study evaluating rhBMP-2 / absorbable collagen sponge for maxillary sinus floor augmentation. Int J Peri- odontics Restorative Dent 1997; 17: 11–25. 57 Armstrong D, Cook S, Kisecki E: Non-unions: Clini- cal experiences. Proc. 2nd Int. Conference on Bone Morphogenetic Proteins, Sacramento, California June 4–8, 1997; S. 134. 58 Marx RE: Clinical application of bone biology to mandibular and maxillary reconstruction. Clin Palst Surg 1994; 21: 377–392. 59 Marx RE, Ehler WJ, Peleg M: Mandibular and facial reconstruction: rehabilitation of the head and neck cancer patient. Bone 1996; 19 Suppl 1: 595–625. 60 Marx RE, Caarlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR: Platelet-rich plasma. Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Path 1998; 85: 638–646. 61 Terheyden H: Experimentelle Sinusbodenaugmen- tation: Vergleich verschiedener Trägermaterialien mit und ohne rhOP1 und Vergleich der biologi- schen Faktoren PRP und rhOP1. Sinus-Lift-Konfe- renz Hamburg, 09.09.2000. INTERNATIONAL MAGAZINE OF ORAL IMPLANTOLOGY 1/2000 153